Vanguard Asset Management’s LB Pharmaceuticals LBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LBRX
Vanguard Asset Management's LBRX Position: Q3 2026 in Review
Vanguard Asset Management increased its LB Pharmaceuticals (LBRX) stake by 5.8% in Q3 2026, buying an estimated $25.1K and bringing the position to 11,147 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.
Vanguard Asset Management first reported a position in LBRX in Q2 2026 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.
- Vanguard Asset Management held 11,147 shares of LB Pharmaceuticals worth $428K as of Q3 2026.
- Vanguard Asset Management bought 607 LB Pharmaceuticals shares in Q3 2026, an estimated $25.1K.
- LB Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2236 holding.
- Vanguard Asset Management first reported a position in LB Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 147 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.